Faria CDC, Ribeiro S, Kochi C, Silva APND, Ribeiro BNF, Marçal LT, Santos FHY, Eduardo CPL, Monte O, Longui CA. TSH neurosecretory dysfunction (TSH-nd) in Down syndrome (DS): low risk of progression to Hashimoto's thyroiditis.
ACTA ACUST UNITED AC 2012;
55:628-31. [PMID:
22218446 DOI:
10.1590/s0004-27302011000800018]
[Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2011] [Accepted: 11/10/2011] [Indexed: 11/21/2022]
Abstract
INTRODUCTION
Patients with Down syndrome (DS) often have elevated TSH (hypothalamic origin), which is called TSH neurosecretory dysfunction (TSH-nd). In these cases, there is slight elevation in TSH (5-15 µUI/mL), with normal free T4 and negative thyroid antibodies (AB).
OBJECTIVE
To recognize the risk of progression to Hashimoto's thyroiditis (HT).
SUBJECTS AND METHODS
We retrospectively analyzed 40 DS patients (mean age = 4.5 years), followed up for 6.8 years.
RESULTS
HT was diagnosed in 9/40 patients, three early in monitoring, and six during evolution. In 31/40 patients, TSH-nd diagnosis remained unchanged over the years, with maximum TSH values ranging from 5 to 15 µUI/mL. In this group, free T4 also remained normal and AB were negative. There was a significant TSH reduction (p = 0.017), and normal TSH concentrations (< 5.0 µUI/mL) were observed in 29/31 patients, in at least one moment. No patient had TSH > 15 µUI/mL.
CONCLUSION
DS patients with TSH-nd present low risk of progression to HT (10% for females and 6% for males).
Collapse